Medicare Enrolled

Dr. Amitasha Mann, M.D.

Internal Medicine · Clovis, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
275 W HERNDON AVE, Clovis, CA 93612
5593246200
In practice since 2013 (13 years)
NPI: 1619215837 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mann? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mann

Dr. Amitasha Mann is an internal medicine specialist in Clovis, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Mann performed 1,348 Medicare services across 918 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mann received a total of $2,845 from 37 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 24% volume in CA $2,845 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,348
Medicare services
Top 24% in CA for internal medicine
918
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~104 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
429 $91 $405
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
291 $65 $285
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
125 $80 $263
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
124 $50 $134
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
116 $135 $413
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
64 $32 $69
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
63 $72 $183
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
56 $41 $230
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
29 $2 $9
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
29 $61 $286
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
11 $10 $76
Transitional care management, high complexity
Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem.
11 $231 $873
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,845
Total received (2018-2024)
Avg $406/year across 7 years
Top 22% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
158
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,845 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$557
2023
$314
2022
$207
2021
$379
2020
$161
2019
$461
2018
$765

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$131
GlaxoSmithKline, LLC.
$72
Lilly USA, LLC
$62
ABBVIE INC.
$42
Abbott Laboratories
$41
PFIZER INC.
$37
Bayer Healthcare Pharmaceuticals Inc.
$37
Astellas Pharma US Inc
$29
Amgen Inc.
$27
Exact Sciences Corporation
$23
Verity Pharmaceuticals Inc.
$21
Novo Nordisk Inc
$17
Dexcom, Inc.
$17
Top 3 companies account for 47.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$791
Novo Nordisk Inc
$243
Lilly USA, LLC
$240
Amgen Inc.
$206
PFIZER INC.
$157
GlaxoSmithKline, LLC.
$149
Abbott Laboratories
$89
Boehringer Ingelheim Pharmaceuticals, Inc.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$77
Bayer Healthcare Pharmaceuticals Inc.
$75
Merck Sharp & Dohme Corporation
$74
ABBVIE INC.
$66
Biohaven Pharmaceuticals, Inc.
$61
AbbVie Inc.
$53
Novartis Pharmaceuticals Corporation
$40
Eisai Inc.
$37
Amarin Pharma Inc.
$36
Teva Pharmaceuticals USA, Inc.
$35
Astellas Pharma US Inc
$29
Mannkind Corporation
$26
Regeneron Healthcare Solutions, Inc.
$26
Esperion Therapeutics, Inc.
$23
Exact Sciences Corporation
$23
Verity Pharmaceuticals Inc.
$21
Noden Pharma USA Inc
$20
Dynavax Technologies Corporation
$18
Kowa Pharmaceuticals America, Inc.
$18
Dexcom, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
SANOFI-AVENTIS U.S. LLC
$15
ARBOR PHARMACEUTICALS, INC.
$14
Intercept Pharmaceuticals, Inc.
$13
Medtronic USA, Inc.
$13
Arbor Pharmaceuticals, Inc.
$12
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
MannKind Corporation
$11
Supernus Pharmaceuticals, Inc.
$11
Top 3 companies account for 44.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · Aimovig · AirDuo Digihaler · BASAGLAR · BYDUREON · CHANTIX · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · EVENITY · EVKEEZA · Edarbi · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Heplisav-B · JANUVIA · JARDIANCE · KYPHON Balloon Kyphoplasty · Kerendia · LINZESS · Livalo · MOUNJARO · NEXLETOL · NURTEC ODT · OCALIVA · Otezla · Ozempic · PAXLOVID · PREVNAR - 13 · Prolia · QULIPTA · RYBELSUS · Rybelsus · SHINGRIX · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · TEKTURNA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · Tlando · Tresiba · Trintellix · UBRELVY · Vascepa · Veozah · Victoza · Wegovy · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in Clovis?
Compare internal medicine physicians in the Clovis area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
481
Per 100K population
47.5
County median income
$71,434
Nearest hospital
CLOVIS COMMUNITY MEDICAL CENTER
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mann is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mann experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mann performed 429 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mann receive payments from pharmaceutical companies?
Yes. Dr. Mann received a total of $2,845 from 37 companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mann's costs compare to other internal medicine physicians in Clovis?
Dr. Mann's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →